Kidney Neoplasms

2 researchers across 2 institutions

2 Researchers
2 Institutions
0 Grant PIs
0 High Impact

Research in kidney neoplasms focuses on understanding the biological mechanisms driving the formation and progression of kidney cancers. Investigations explore cellular and molecular pathways involved in tumor initiation, growth, and the processes of metastasis. This work employs a range of methodologies, including laboratory-based studies of cancer cell behavior, analysis of medical imaging data, and the development of computational models. Specific areas of inquiry include the identification of novel therapeutic targets and the application of advanced imaging techniques for diagnosis and monitoring.

The study of kidney neoplasms holds particular relevance for Arkansas, a state that faces significant public health challenges. Research in this area contributes to efforts to improve cancer outcomes and address disparities in cancer incidence and mortality within the state's population. Understanding the unique demographic and health factors present in Arkansas can inform the development of more effective prevention, early detection, and treatment strategies tailored to the needs of its residents.

This field of study benefits from interdisciplinary collaboration, drawing on expertise in medical imaging, machine learning, and general medical research. Engagement across multiple institutions within Arkansas fosters a comprehensive approach to tackling complex questions related to kidney cancer.

AI-generated overview
Filter by institution:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Aditi Chaurasia UAMS 6 56
Gasinee Reed Arkansas Colleges of Health Education 2 6

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
6,652 works in 2026
+0.4% CAGR 2018–2026
Leadership concentration
7.0% held by global top 5 institutions
Fragmented HHI 30
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2026 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 2,602
  2. 2 Memorial Sloan Kettering Cancer Center 2,578
  3. 3 Cleveland Clinic 2,451
  4. 4 Harvard University 2,269
  5. 5 Dana-Farber Cancer Institute 1,887
Browse All 2 Researchers in Directory